海洋制造的医疗器械和治疗传递系统
Paula Isabel Hueso-Jiménez1,2,3, David T Wu4,5,6,7, Chris Hyeongseop Keum1,2,8,9
1Harvard Medical School, Boston, Massachusetts, USA.
Advanced healthcare materials
|March 14, 2026
概括
海洋生物材料为医疗器械,组织工程和伤口愈合提供独特的特性. 可持续生产和生物技术的整合是患者可访问性和循环经济原则的关键.
科学领域:
- 生物材料科学 生物材料科学
- 海洋生物技术 海洋生物技术
- 再生医学是一种再生医学.
背景情况:
- 海洋产品具有独特的物理,化学和生物特性,有利于生物医学应用.
- 这些特性包括机械增强,水下粘附,膨胀能力和生物相容性,支持组织工程和伤口愈合至关重要的细胞功能.
研究的目的:
- 审查海洋衍生生物材料和医疗器械.
- 分析它们的自然特性,并强调在支架,粘合剂和药物输送系统中的优势.
- 讨论海洋生物作为先进生物医学应用的来源的潜力.
主要方法:
- 关于包括Porifera,Cnidaria,Mollusca,Chordata,Chlorophyta和Cyanobacteria在内的海洋生物的文献综述.
- 分析海洋衍生产品的自然特性.
- 在支架,粘合剂和药物输送系统中应用的评估.
主要成果:
- 海洋来源提供了多功能生物材料,具有适合组织工程和伤口愈合的特性.
- 从海洋生物中获得的支架,粘合剂和药物输送系统显示出显著的前景.
- 成功的临床翻译需要适当的控制和可持续的扩展过程.
结论:
- 海洋生物材料在医疗器械和再生医学领域是一个有前途的前沿.
- 生物技术和废物利用为可持续生产和融入循环经济提供了途径.
- 需要进一步的研究和开发,才能充分发挥这些海洋资源的临床潜力.
更多相关视频
09:02Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
12.5K
07:13Applications of In Vivo Functional Testing of the Rat Tibialis Anterior for Evaluating Tissue Engineered Skeletal Muscle Repair
Published on: October 7, 2016
14.8K
相关概念视频
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
85
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
85
01:27Drug Delivery Systems: Different Types
166
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
166
01:21Intrauterine Drug Delivery Systems
100
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
100
01:18Transdermal Drug Delivery Systems
94
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
94
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
73
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
73
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79